CSE: BUX | OTCQB: BMKDF

BioMark™ Diagnostics

BioMark Diagnostics to Conduct Validation Studies for its Patented Assays in Patients with Lung Cancer

Dr. James Bond of Surrey Memorial Hospital to act as Principal Investigator

BioMark Diagnostics to Conduct Validation Studies (PDF)

 

———————————————

Contact BioMark Diagnostics

Canadian Stock Exchange

CSE: BUX
BioMark Diagnostics Inc.
CAD $0.55
+0.00 (0.00%)
Last updated: Market close • Delayed quote
View Live Quote on Yahoo Finance →

OTC Markets

OTCQB: BMKDF
BioMark Diagnostics Inc.
USD $0.40
+0.00 (0.00%)
Last updated: Market close • Delayed quote
View Live Quote on Yahoo Finance →

Frankfurt Stock Exchange

FSE: 20B
BioMark Diagnostics Inc.
€0.36
+0.00 (0.00%)
Last updated: Market close • Delayed quote
View Live Quote on Yahoo Finance →

Share This Post

Facebook
X
LinkedIn
Reddit
VK
StumbleUpon
Telegram
XING
WhatsApp
Threads
Email
Print

Related News

Sign up for the latest BioMark news